Sm\u011bs CagriSema kombinuje:<\/p>\n
CagriSema nep\u0159edstavuje nov\u00fd peptid, n\u00fdbr\u017e kombinuje dv\u011b dob\u0159e prostudovan\u00e9 zkouman\u00e9 l\u00e1tky s komplement\u00e1rn\u00edmi biologick\u00fdmi mechanismy.<\/p>\n
Semaglutid je Agonista receptoru GLP-1<\/strong>, zat\u00edmco Cagrilintide je dlouhodob\u011b p\u016fsob\u00edc\u00ed analog amylinu<\/strong>. Spole\u010dn\u011b umo\u017e\u0148uj\u00ed v\u00fdzkumn\u00edk\u016fm zkoumat dv\u011b hormon\u00e1ln\u00ed dr\u00e1hy, kter\u00e9 reguluj\u00ed chu\u0165 k j\u00eddlu, sytost, vyprazd\u0148ov\u00e1n\u00ed \u017ealudku a energetickou bilanci prost\u0159ednictv\u00edm odli\u0161n\u00fdch fyziologick\u00fdch mechanism\u016f.<\/p>\n Chcete si v Evrop\u011b zakoupit CagriSema? Spole\u010dnost Life Peptide dod\u00e1v\u00e1 CagriSema vysok\u00e9 \u010distoty pro laboratorn\u00ed v\u00fdzkum a zaji\u0161\u0165uje spolehlivou dopravu po cel\u00e9 EU.<\/em><\/p>\n Mezi v\u0161emi sou\u010dasn\u00fdmi kombinacemi metabolick\u00fdch peptid\u016f m\u00e1 CagriSema jednu z nejpevn\u011bj\u0161\u00ed klinick\u00e9 d\u016fkazn\u00ed z\u00e1klady<\/strong>.<\/p>\n Jednotliv\u00e9 slo\u017eky p\u0159isp\u00edvaj\u00ed dopl\u0148kovou biologi\u00ed.<\/p>\n Semaglutid<\/strong><\/a><\/p>\n Kagrilintid<\/strong><\/a><\/p>\n Proto\u017ee tyto dr\u00e1hy reguluj\u00ed p\u0159\u00edjem potravy prost\u0159ednictv\u00edm odli\u0161n\u00fdch mechanism\u016f, CagriSema se stala jedn\u00edm z p\u0159edn\u00ed zkouman\u00e9 kombinace v oblasti v\u00fdzkumu obezity a metabolismu<\/strong>.<\/p>\n Semaglutid (5 mg)<\/strong><\/p>\n Agonista receptoru GLP-1 s rozs\u00e1hlou z\u00e1kladnou klinick\u00fdch d\u016fkaz\u016f v oblasti v\u00fdzkumu obezity a metabolismu. Publikovan\u00e9 studie stanovily semaglutid jako jednu ze z\u00e1kladn\u00edch l\u00e1tek v modern\u00ed inkretinov\u00e9 biologii.<\/p>\n Cagrilintid (5 mg)<\/strong><\/p>\n Dlouhodob\u011b p\u016fsob\u00edc\u00ed analog amylinu zkouman\u00fd v oblasti regulace chuti k j\u00eddlu, sign\u00e1l\u016f sytosti a vypr\u00e1zd\u0148ov\u00e1n\u00ed \u017ealudku. Proto\u017ee se zam\u011b\u0159uje na amylinov\u00e9 receptory sp\u00ed\u0161e ne\u017e na receptory GLP-1, poskytuje dopl\u0148kov\u00e9 metabolick\u00e9 sign\u00e1ly.<\/p>\n Jedn\u00edm z hlavn\u00edch c\u00edl\u016f v metabolick\u00e9m v\u00fdzkumu je prozkoumat, zda c\u00edlen\u00ed na v\u00edce hormon\u00e1ln\u00edch drah p\u0159in\u00e1\u0161\u00ed \u0161ir\u0161\u00ed fyziologick\u00e9 \u00fa\u010dinky<\/strong> ne\u017e aktivace jedin\u00e9ho receptorov\u00e9ho syst\u00e9mu.<\/p>\n Semaglutide poskytuje Agonismus receptoru GLP-1<\/strong>.<\/p>\n Cagrilintide poskytuje signaling amylinov\u00e9ho receptoru<\/strong>.<\/p>\n Na rozd\u00edl od mnoha experiment\u00e1ln\u00edch peptidov\u00fdch sm\u011bs\u00ed byla tato kombinace hodnocena v v\u00edce klinick\u00fdch studi\u00ed na lidech<\/strong>, kter\u00e1 prok\u00e1zala v\u011bt\u0161\u00ed sn\u00ed\u017een\u00ed hmotnosti ne\u017e u samotn\u00e9ho semaglutidu nebo cagrilintidu<\/strong> p\u0159i zachov\u00e1n\u00ed p\u0159ijateln\u00e9ho profilu sn\u00e1\u0161enlivosti. Tato zji\u0161t\u011bn\u00ed stanovila p\u0159\u00edpravek CagriSema jako jednu z nejintenzivn\u011bji zkouman\u00fdch kombinovan\u00fdch terapi\u00ed v oblasti metabolick\u00e9ho v\u00fdzkumu.<\/p>\n CagriSema m\u00e1 jednu z nejsiln\u011bj\u0161\u00edch d\u016fkazn\u00edch z\u00e1kladen mezi zkouman\u00fdmi kombinacemi metabolick\u00fdch peptid\u016f.<\/p>\n Publikovan\u00e9 studie f\u00e1ze II a f\u00e1ze III zkoumaly tuto kombinaci u dosp\u011bl\u00fdch s obezitou a diabetem 2. typu a prok\u00e1zaly v\u00fdznamn\u00e9 zlep\u0161en\u00ed t\u011blesn\u00e9 hmotnosti a glykemick\u00e9 kontroly ve srovn\u00e1n\u00ed s jednotliv\u00fdmi slo\u017ekami. Prob\u00edhaj\u00edc\u00ed klinick\u00e9 programy REDEFINE a REIMAGINE nad\u00e1le hodnot\u00ed jej\u00ed dlouhodobou \u00fa\u010dinnost a bezpe\u010dnost.<\/p>\n Na rozd\u00edl od mnoha v\u00fdzkumn\u00fdch sm\u011bs\u00ed je CagriSema podporov\u00e1na specializovan\u00e9 kombinovan\u00e9 studie<\/strong> ne\u017e pouze studiemi jeho jednotliv\u00fdch peptid\u016f.<\/p>\n \u00c7a\u011fr\u0131 Sema<\/strong><\/p>\n CagriTirz<\/strong><\/a><\/p>\n CagriReta<\/strong><\/a><\/p>\n V\u00fdzkumn\u00edci vol\u00ed mezi t\u011bmito formulacemi na z\u00e1klad\u011b metabolick\u00fdch drah, kter\u00e9 cht\u011bj\u00ed zkoumat, a dostupn\u00fdch klinick\u00fdch d\u016fkaz\u016f.<\/p>\n Publikovan\u00e9 \u00fadaje o bezpe\u010dnosti p\u0159\u00edpravku CagriSema popisuj\u00ed p\u0159edev\u0161\u00edm gastrointestin\u00e1ln\u00ed ne\u017e\u00e1douc\u00ed \u00fa\u010dinky, v\u010detn\u011b nevolnost, zvracen\u00ed, pr\u016fjem a sn\u00ed\u017een\u00e1 chu\u0165 k j\u00eddlu, zejm\u00e9na b\u011bhem zvy\u0161ov\u00e1n\u00ed d\u00e1vky<\/strong>. Nap\u0159\u00ed\u010d klinick\u00fdmi studiemi byly tyto p\u0159\u00edhody obvykle m\u00edrn\u00e9 a\u017e st\u0159edn\u011b z\u00e1va\u017en\u00e9 a odpov\u00eddaly zn\u00e1m\u00fdm bezpe\u010dnostn\u00edm profil\u016fm agonist\u016f GLP-1 receptor\u016f a analog\u016f amylinu.<\/p>\n Aplikace: laboratorn\u00ed a analytick\u00fd v\u00fdzkum \u00dalo\u017ei\u0161t\u011b<\/strong>Neotev\u0159en\u00e9 lyofilizovan\u00e9 lahvi\u010dky jsou nejl\u00e9pe skladov\u00e1ny chlazen\u00e9 p\u0159i 2\u20138 \u00b0C<\/strong>, co\u017e je metoda skladov\u00e1n\u00ed potvrzen\u00e1 na\u0161\u00edm v\u00fdrobn\u00edm partnerem a vhodn\u00e1 a\u017e po dobu 24 m\u011bs\u00edc\u016f. Preferuje se chlazen\u00ed, proto\u017ee minimalizuje zbyte\u010dn\u00e9 cykly zmrazov\u00e1n\u00ed a rozmrazov\u00e1n\u00ed b\u011bhem b\u011b\u017en\u00e9 manipulace. Pokud je vy\u017eadov\u00e1no podstatn\u011b del\u0161\u00ed skladov\u00e1n\u00ed, lze zmrazen\u00e9 uchov\u00e1vat i neotev\u0159en\u00e9 lyofilizovan\u00e9 lahvi\u010dky. Po rekonstituci v\u017edy skladujte p\u0159i 2\u20138 \u00b0C a nezmrazujte.<\/p>\n P\u0159elomov\u00e1 studie f\u00e1ze II prokazuj\u00edc\u00ed v\u011bt\u0161\u00ed \u00fabytek hmotnosti a lep\u0161\u00ed glykemickou kontrolu p\u0159i pou\u017eit\u00ed kombinace ve srovn\u00e1n\u00ed s kter\u00fdmkoli peptidem samotn\u00fdm.<\/p>\n Kl\u00ed\u010dov\u00e1 studie podporuj\u00edc\u00ed dal\u0161\u00ed v\u00fdvoj fixn\u00ed kombinace a poskytuj\u00edc\u00ed dodate\u010dn\u00e9 \u00fadaje o \u00fa\u010dinnosti a bezpe\u010dnosti.<\/p>\n Z\u00e1sadn\u00ed studie f\u00e1ze II, kter\u00e1 stanovila cagrilintid jako p\u0159edn\u00ed dlouhodob\u011b p\u016fsob\u00edc\u00ed analog amylinu.<\/p>\n Pr\u016flomov\u00e1 studie STEP-1, kter\u00e1 stanovila semaglutid jako z\u00e1kladn\u00ed k\u00e1men modern\u00edho v\u00fdzkumu obezity a metabolick\u00fdch onemocn\u011bn\u00ed.<\/p>\n Co je sm\u011bs CagriSema?<\/strong><\/p>\n Sm\u011bs CagriSema kombinuje cagrilintid (5 mg) a semaglutid (5 mg) v jedn\u00e9 lyofilizovan\u00e9 lahvi\u010dce. Je ur\u010dena pro laboratorn\u00ed v\u00fdzkum zkoumaj\u00edc\u00ed dopl\u0148kov\u00e9 metabolick\u00e9 dr\u00e1hy zahrnuj\u00edc\u00ed signalizaci receptor\u016f pro amylin a GLP-1.<\/p>\n Kter\u00e9 peptidy jsou obsa\u017eeny v p\u0159\u00edpravku CagriSema?<\/strong><\/p>\n Ka\u017ed\u00e1 lahvi\u010dka obsahuje:<\/p>\n Tyto peptidy spole\u010dn\u011b p\u016fsob\u00ed na dva dopl\u0148kov\u00e9 hormon\u00e1ln\u00ed syst\u00e9my, kter\u00e9 se pod\u00edlej\u00ed na regulaci chuti k j\u00eddlu, sytosti, vyprazd\u0148ov\u00e1n\u00ed \u017ealudku a energetick\u00e9 rovnov\u00e1ze.<\/p>\n Pro\u010d se Cagrilintide a Semaglutide kombinuj\u00ed?<\/strong><\/p>\n Semaglutid aktivuje receptor GLP-1, zat\u00edmco Cagrilintid je dlouhodob\u011b p\u016fsob\u00edc\u00ed analog amylinu. Proto\u017ee reguluj\u00ed metabolismus prost\u0159ednictv\u00edm odli\u0161n\u00fdch fyziologick\u00fdch dr\u00e1h, v\u00fdzkumn\u00edci tuto kombinaci zkoumaj\u00ed, aby l\u00e9pe porozum\u011bli komplement\u00e1rn\u00ed metabolick\u00e9 signalizaci. Na rozd\u00edl od mnoha peptidov\u00fdch sm\u011bs\u00ed byla tato kombinace hodnocena v c\u00edlen\u00fdch klinick\u00fdch studi\u00edch na lidech.<\/p>\n Jak\u00e9 oblasti v\u00fdzkumu se b\u011b\u017en\u011b zab\u00fdvaj\u00ed sm\u011bs\u00ed CagriSema?<\/strong><\/p>\n Publikovan\u00fd v\u00fdzkum zkoumal p\u0159\u00edpravek CagriSema v oblasti regulace chuti k j\u00eddlu, sign\u00e1l\u016f sytosti, regulace t\u011blesn\u00e9 hmotnosti, energetick\u00e9 bilance, vyprazd\u0148ov\u00e1n\u00ed \u017ealudku, glykemick\u00e9 kontroly a komplement\u00e1rn\u00ed biologie amylinu a GLP-1.<\/p>\n Jak se CagriSema li\u0161\u00ed od CagriTirz?<\/strong><\/p>\n Ob\u011b sm\u011bsi obsahuj\u00ed kagrilintid, ale CagriSema ho kombinuje se semaglutidem, zat\u00edmco CagriTirz ho kombinuje s tirzepatidem. CagriTirz p\u0159id\u00e1v\u00e1 agonismus GIP receptoru, kde\u017eto CagriSema je v sou\u010dasnosti podpo\u0159ena nejrozs\u00e1hlej\u0161\u00edmi specializovan\u00fdmi klinick\u00fdmi d\u016fkazy pro kombinaci amylinu a GLP-1.<\/p>\n Lze v\u00fdzkum p\u0159\u00edpravku CagriSema aplikovat p\u0159\u00edmo na tuto sm\u011bs?<\/strong><\/p>\n Ano, na rozd\u00edl od mnoha v\u00fdzkumn\u00fdch sm\u011bs\u00ed byl p\u0159\u00edpravek CagriSema zkoum\u00e1n jako fixn\u00ed kombinace v c\u00edlen\u00fdch klinick\u00fdch studi\u00edch. A\u010dkoli se tento v\u00fdzkum t\u00fdk\u00e1 farmaceutick\u00fdch formulac\u00ed pou\u017eit\u00fdch v t\u011bchto studi\u00edch, a nikoli tohoto konkr\u00e9tn\u00edho produktu, poskytuje p\u0159\u00edm\u00fd d\u016fkaz o biologick\u00e9 kombinaci Cagrilintidu a Semaglutidu.<\/p>\n Lze v Evrop\u011b koupit CagriSema?<\/strong><\/p>\n Ano. Zas\u00edl\u00e1me p\u0159\u00edpravek CagriSema do v\u011bt\u0161iny evropsk\u00fdch zem\u00ed pomoc\u00ed spolehliv\u00fdch kur\u00fdrn\u00edch slu\u017eeb. Dostupn\u00e9 zp\u016fsoby dopravy a dodac\u00ed lh\u016fty se zobraz\u00ed b\u011bhem dokon\u010den\u00ed objedn\u00e1vky na z\u00e1klad\u011b va\u0161\u00ed c\u00edlov\u00e9 destinace.<\/p>\n Je tento produkt ur\u010den k lidsk\u00e9mu pou\u017eit\u00ed?<\/strong><\/p>\n Produkt CagriSema Blend dod\u00e1van\u00fd spole\u010dnost\u00ed Life Peptide je ur\u010den v\u00fdhradn\u011b pro laboratorn\u00ed a analytick\u00fd v\u00fdzkum. Nen\u00ed ur\u010den k lidsk\u00e9 spot\u0159eb\u011b, diagnostice, l\u00e9\u010db\u011b ani prevenci nemoc\u00ed. Ve\u0161ker\u00e9 zm\u00ednky o publikovan\u00fdch studi\u00edch p\u0159edstavuj\u00ed shrnut\u00ed v\u011bdeck\u00e9 literatury t\u00fdkaj\u00edc\u00ed se dan\u00e9 kombinace peptid\u016f, nikoli zam\u00fd\u0161len\u00e9ho pou\u017eit\u00ed tohoto produktu.<\/p>\n Kombinace cagrilintidu a semaglutidu spojuje signalizaci analogu amylinu s aktivac\u00ed GLP-1 receptor\u016f a vytv\u00e1\u0159\u00ed tak dvoucestn\u00fd metabolick\u00fd v\u00fdzkumn\u00fd model.<\/p>\n Pro komparativn\u00ed r\u00e1mce mohou v\u00fdzkumn\u00edci tak\u00e9 zkoumat:<\/p>\n Semaglutid<\/a> \u2014 agonist GLP-1 receptor\u016f Tato kombinace se b\u011b\u017en\u011b vyu\u017e\u00edv\u00e1 ve v\u00fdzkumu zkoumaj\u00edc\u00edm sign\u00e1ly sytosti spolu s metabolickou regulac\u00ed zprost\u0159edkovanou inkretiny.<\/p>\n Pro dal\u0161\u00ed kontext viz Pr\u016fvodce v\u00fdzkumem metabolismu GLP-1<\/a> a souvisej\u00edc\u00edch slou\u010denin v r\u00e1mci Metabolick\u00fd v\u00fdzkum<\/a>.<\/p>\n POZN\u00c1MKA<\/strong>Toto je pouze pro vzd\u011bl\u00e1vac\u00ed \u00fa\u010dely a nep\u0159edstavuje l\u00e9ka\u0159skou radu.<\/p>\n Z\u0159eknut\u00ed se odpov\u011bdnosti<\/strong> CagriSema Blend 10 mg je v\u00fdzkumn\u00e1 metabolick\u00e1 peptidov\u00e1 formulace kombinuj\u00edc\u00ed cagrilintid (5 mg) a semaglutid (5 mg v jedn\u00e9 lyofilizovan\u00e9 lahvi\u010dce. Je ur\u010dena pro laboratorn\u00ed v\u00fdzkum a kombinuje signalizaci receptor\u016f pro amylin a GLP-1 \u2013 dv\u011b dopl\u0148kov\u00e9 dr\u00e1hy, kter\u00e9 se staly jednou z nejintenzivn\u011bji zkouman\u00fdch kombinac\u00ed v modern\u00edm metabolick\u00e9m v\u00fdzkumu.<\/p>\n ||<\/p>\n \u010cistota \u226598% | N\u00e1kup v Evrop\u011b s dopravou od 5 \u20ac | Mo\u017enost volby dopravy zdarma | P\u0159ij\u00edm\u00e1me platby kartou<\/p>","protected":false},"featured_media":1050,"template":"","meta":[],"product_brand":[],"product_cat":[19],"product_tag":[257,248,160,139,247,153,156,252,159,246,316],"class_list":["post-1057","product","type-product","status-publish","has-post-thumbnail","product_cat-metabolic-research-peptides","product_tag-appetite-regulation","product_tag-energy-balance","product_tag-energy-balance-research","product_tag-glp-1-research","product_tag-metabolic-peptide","product_tag-metabolic-research","product_tag-multi-receptor-agonist","product_tag-obesity-research","product_tag-satiety-signaling","product_tag-weight-loss-peptide","product_tag-weight-management-research","first","instock","taxable","shipping-taxable","purchasable","product-type-simple"],"_links":{"self":[{"href":"https:\/\/life-peptide.com\/cs\/wp-json\/wp\/v2\/product\/1057","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/life-peptide.com\/cs\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/life-peptide.com\/cs\/wp-json\/wp\/v2\/types\/product"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/life-peptide.com\/cs\/wp-json\/wp\/v2\/media\/1050"}],"wp:attachment":[{"href":"https:\/\/life-peptide.com\/cs\/wp-json\/wp\/v2\/media?parent=1057"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/life-peptide.com\/cs\/wp-json\/wp\/v2\/product_brand?post=1057"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/life-peptide.com\/cs\/wp-json\/wp\/v2\/product_cat?post=1057"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/life-peptide.com\/cs\/wp-json\/wp\/v2\/product_tag?post=1057"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nPro\u010d na CagriSema z\u00e1le\u017e\u00ed v metabolick\u00e9m v\u00fdzkumu<\/strong><\/h4>\n
\n
\n
\nDv\u011b slo\u017eky p\u0159\u00edpravku CagriSema<\/strong><\/h4>\n
Pro\u010d v\u00fdzkumn\u00edci kombinuj\u00ed cagrilintid se semaglutidem<\/strong><\/h4>\n
Lidsk\u00fd a preklinick\u00fd v\u00fdzkum<\/strong><\/h4>\n
\nJak se CagriSema li\u0161\u00ed od jin\u00fdch metabolick\u00fdch sm\u011bs\u00ed<\/strong><\/h4>\n
\n
\n
\n
Publikovan\u00e1 bezpe\u010dnostn\u00ed opat\u0159en\u00ed<\/strong><\/h4>\n
\nVlastnosti produktu<\/strong><\/h4>\n
\nPou\u017eit\u00ed omezen\u00e9: nen\u00ed ur\u010deno k lidsk\u00e9 spot\u0159eb\u011b; pro l\u00e9ka\u0159sk\u00e9, veterin\u00e1rn\u00ed ani kosmetick\u00e9 pou\u017eit\u00ed
\nVyrobeno v za\u0159\u00edzen\u00edch spl\u0148uj\u00edc\u00edch spr\u00e1vnou v\u00fdrobn\u00ed praxi (GMP) za p\u0159\u00edsn\u00fdch protokol\u016f kontroly kvality.
\nKa\u017ed\u00e1 \u0161ar\u017ee je po v\u00fdrob\u011b pe\u010dliv\u011b laboratorn\u011b testov\u00e1na (Certifik\u00e1t o anal\u00fdze najdete pod obr\u00e1zky produkt\u016f).
\nLyofilizov\u00e1no (su\u0161eno mrazem) pro maxim\u00e1ln\u00ed stabilitu a prodlou\u017eenou trvanlivost.
\nUzav\u0159eno ve steriln\u00edch lahvi\u010dk\u00e1ch, p\u0159ipraveno k rekonstituci.
\n\u010cistota: \u2265 98% (HPLC)
\nVzhled: b\u00edl\u00fd lyofilizovan\u00fd pr\u00e1\u0161ek
\nSlo\u017een\u00ed: Cagrilintid 5 mg + Semaglutid 5 mg
\nMolekul\u00e1rn\u00ed vzorec Cagrilintide \/ Semaglutide: C194<\/sub>H312<\/sub>N54<\/sub>O59<\/sub> S2<\/sub> \/ C187<\/sub>H291<\/sub>N4<\/sub>5<\/sub>O59<\/sub>
\nMolekulov\u00e1 hmotnost Cagrilintide \/ Retatrutide: 4409.01 \/ 4113.64
\nSekvence Cagrilintid: {diacid-C20-\u03b3-Glu} KCNTATCATQRLAEFLRHSSNNFGPILPPTNVGSNTP-NH2
\nSekvence Semaglutidu: H-Aib-EGTFTSDVSSYLEGQAA-K(18Oct-\u03b3-Glu-AEEA-AEEA)-EFIAWLVRGRG<\/p>\n
\nKl\u00ed\u010dov\u00e9 publikovan\u00e9 studie<\/strong><\/h4>\n
\n
\n
\n
\n
\n\u010casto kladen\u00e9 ot\u00e1zky<\/strong><\/h4>\n
\n
\nSouvisej\u00edc\u00ed v\u00fdzkumn\u00fd kontext<\/strong><\/h4>\n
\nKagrilintid<\/a> \u2014 analog amylinu
\nTirzepatid<\/a> \u2014 du\u00e1ln\u00ed agonista GLP-1\/GIP
\nSm\u011bsi na b\u00e1zi cagrilinitidu \u2013 roz\u0161\u00ed\u0159en\u00e9 kombina\u010dn\u00ed modely<\/p>\n
\nTento produkt je prod\u00e1v\u00e1n pouze pro v\u00fdzkumn\u00e9 \u00fa\u010dely. Nen\u00ed ur\u010den k diagnostice, l\u00e9\u010db\u011b, vyl\u00e9\u010den\u00ed nebo prevenci jak\u00fdchkoli onemocn\u011bn\u00ed. Kupuj\u00edc\u00ed p\u0159eb\u00edr\u00e1 plnou odpov\u011bdnost za \u0159\u00e1dnou manipulaci a pou\u017eit\u00ed.<\/p>","protected":false},"excerpt":{"rendered":"